Načítá se...
RAB6C is an independent prognostic factor of estrogen receptor-positive/progesterone receptor-negative breast cancer
The majority of breast cancer tumors are estrogen receptor-positive (ER(+)) and can be treated with endocrine therapy. However, certain patients may exhibit a good prognosis without systemic treatment. The aim of the present study was to identify novel prognostic factors for patients with ER(+) brea...
Uloženo v:
| Vydáno v: | Oncol Lett |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
D.A. Spandidos
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6923975/ https://ncbi.nlm.nih.gov/pubmed/31897114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.11109 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|